| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 08/15/2001 | CN1308622A Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308621A Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308620A Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308074A Chiralheteraryl cyan alcohol and its derivative, preparation and use |
| 08/15/2001 | CN1308061A Mercaptan and sulfenyl-(methyl) acrylate compound and their application |
| 08/15/2001 | CN1308060A Mercaptan and sulfenyl-(methyl) acrylate compound and their application |
| 08/14/2001 | US6274742 Method for synthesis of N-homocysteine thiolactonyl retinamide |
| 08/14/2001 | US6274741 Process for the preparation of acyl heteroaromatic compounds from heteroaromatic compounds by metal ion exchanged clays |
| 08/14/2001 | US6274620 Thiophene integrin inhibitors |
| 08/14/2001 | US6274619 Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors |
| 08/14/2001 | US6274601 Methods of inhibiting ulcerative mucositis |
| 08/14/2001 | US6274590 Administering 3,4-diarylthiophene derivative to treat eczema, burns, psoriasis, and dermatitis |
| 08/14/2001 | US6274584 Peptide derivatives; bioavailability; enzyme resistance; milk and wool production |
| 08/14/2001 | US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay |
| 08/14/2001 | CA2187591C Novel tertiary heterocyclic amines; process for preparing them and pharmaceutical compositions containing them |
| 08/09/2001 | WO2001057046A1 Method of converting functional group through halogen-metal exchange reaction |
| 08/09/2001 | WO2001057037A1 Platelet adp receptor inhibitors |
| 08/09/2001 | WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001056554A2 Use of retinoid-type compounds as antibacterial agents |
| 08/09/2001 | WO2001056538A1 Novel coupler for use in oxidative hair dyeing |
| 08/09/2001 | WO2001019814A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 08/09/2001 | WO2001019788A3 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 08/09/2001 | WO2001010834A9 Antibacterial agents |
| 08/09/2001 | US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/09/2001 | US20010012848 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor |
| 08/09/2001 | US20010012596 Oxime ester photoinitiators |
| 08/09/2001 | CA2368510A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/08/2001 | EP1122291A2 Layered organic-inorganic perovskites having metal-deficient inorganic frameworks |
| 08/08/2001 | EP1121342A1 Diaminopropionic acid derivatives |
| 08/08/2001 | EP1121125A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 08/08/2001 | EP1121118A1 Formamides as therapeutic agents |
| 08/08/2001 | CN1069164C Microbicidal composition based on dibromo-thiopheno-carboxylic acid derivatives |
| 08/07/2001 | US6271247 Binding to neuropeptide receptors |
| 08/07/2001 | US6271227 Anticoagulants |
| 08/07/2001 | US6271180 Substituted phenyl keto enols as pesticides and herbicides |
| 08/02/2001 | WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 08/02/2001 | WO2001055111A1 Biaryl compounds, their preparation and their use in therapy |
| 08/02/2001 | WO2000076971A3 Serine protease inhibitors |
| 08/02/2001 | US20010011091 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 08/01/2001 | EP1120413A1 Triketone derivative and herbicide |
| 08/01/2001 | EP1119570A1 Tricyclic delta3-piperidines as pharmaceuticals |
| 08/01/2001 | EP1119542A1 Prostaglandin receptor ligands |
| 08/01/2001 | CN1306534A Thienopyrimidines |
| 08/01/2001 | CN1306508A Hydroxamic acid derivatives as inhibitors or prodn. of human CD23 and of TNF release |
| 08/01/2001 | CN1305993A Cyclic guanyl preparation used as nitrogen oxide synthetic enzyme inhibitor |
| 08/01/2001 | CN1305708A Derivant and microbe killing compsns. of dibromide-thiophene-carboxylic acid |
| 07/31/2001 | US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis. |
| 07/31/2001 | US6268313 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 07/26/2001 | WO2001053321A2 Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers |
| 07/26/2001 | WO2001053287A2 Di(het)arylaminothiophene derivatives |
| 07/26/2001 | WO2001053286A1 Di(het)arylaminothiophene derivatives |
| 07/26/2001 | WO2001053267A1 Compounds exhibiting thrombopoietin receptor agonism |
| 07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001019811A3 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv |
| 07/26/2001 | US20010009921 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/26/2001 | US20010009917 Reducing associated adverse effects; 5-lipoxygenase inhibitor, useful in treatment of conditions related to elevated leukotriene levels |
| 07/26/2001 | DE10002424A1 New 3,4-substituted 2-N,N-di(het)arylamino-thiophene derivatives, used in organic light-emitting diodes and organic photovoltaic components |
| 07/26/2001 | CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 07/25/2001 | EP1117661A1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP0877745B1 N-( 1,2,4] triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
| 07/25/2001 | EP0854861B1 Oxyamino oxime ethers, methods and intermediate products for their production, and agents containing them and used for controlling harmful fungi and pests |
| 07/25/2001 | EP0820437B1 Hydrazonoacetic acid amides and the use thereof as pesticides |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase |
| 07/25/2001 | CN1305453A Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same |
| 07/25/2001 | CN1305377A Methods for increasing levels of acetylcholine |
| 07/25/2001 | CN1305343A Methods for increasing levels of acetylchotine |
| 07/25/2001 | CN1305342A Methods for reducing levels of homocysteine and C-reactive protein |
| 07/25/2001 | CN1068883C Process for synthesis of vinyl sulfenic acid derivatives |
| 07/24/2001 | US6265583 Cyclic sulfone containing retroviral protease inhibitors |
| 07/24/2001 | US6265575 Thrombin inhibitors |
| 07/24/2001 | US6265510 Thiol and sulfur-containing O-(meth)acrylate compounds and use thereof |
| 07/24/2001 | US6265423 Skin disorders; anticancer agents |
| 07/19/2001 | WO2001051479A2 Tricyclic compounds with antiviral activity |
| 07/19/2001 | WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists |
| 07/19/2001 | WO2001051456A2 Antibacterial agents |
| 07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2000076970A3 Serine protease inhibitors |
| 07/19/2001 | WO2000073296A3 3-heteroarylalkyl substituted gaba analogs |
| 07/19/2001 | US20010008902 Reduction of an unsaturated thiazolidine-2,4-dione derivative with metallic aluminum in a protic solvent; purity; antidiabetic agents |
| 07/19/2001 | US20010008890 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 07/19/2001 | CA2397575A1 Antibacterial agents |
| 07/19/2001 | CA2396560A1 Tricyclic compounds and method of treating herpes virus |
| 07/19/2001 | CA2396007A1 Piperidine and piperazine derivatives |
| 07/18/2001 | EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds |
| 07/18/2001 | EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
| 07/18/2001 | EP1115702A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 07/18/2001 | EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115694A1 Substituted n-aliphatic-n-aromatic (tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 07/18/2001 | EP1115286A1 Methods for treating or preventing viral infections and associated diseases |
| 07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/18/2001 | CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |